Recent advances of field-effect transistor technology for infectious diseases

A Panahi, D Sadighbayan, S Forouhi, E Ghafar-Zadeh - Biosensors, 2021 - mdpi.com
Field-effect transistor (FET) biosensors have been intensively researched toward label-free
biomolecule sensing for different disease screening applications. High sensitivity, incredible …

A systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-19

NA Makoah, T Tipih, MM Litabe, M Brink… - Future …, 2022 - Taylor & Francis
Aim: The aim of this study was to investigate the utility of serological tests for the diagnosis of
COVID-19 during the first week of symptom onset in patients confirmed with the real-time RT …

SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals

A Ruggiero, C Piubelli, L Calciano, S Accordini… - …, 2022 - thelancet.com
Background Currently, evaluation of the IgG antibodies specific for the SARS-CoV-2 Spike
protein following vaccination is used worldwide to estimate vaccine response. Limited data …

Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies

HT Zedan, HM Yassine, DW Al-Sadeq, N Liu… - Scientific reports, 2022 - nature.com
Rapid and accurate measurement of the severe acute respiratory syndrome coronavirus 2
(SARS-CoV2)-specific neutralizing antibodies (nAbs) is paramount for monitoring immunity …

Microarray-based detection of antibodies against SARS-CoV-2 proteins, common respiratory viruses and type I interferons

E Savvateeva, M Filippova, V Valuev-Elliston… - Viruses, 2021 - mdpi.com
A microarray-based assay to detect IgG and IgM antibodies against betacoronaviruses
(SARS-CoV-2, SARS, MERS, OC43, and HKU1), other respiratory viruses and type I …

[HTML][HTML] Performance evaluation of novel fluorescent-based lateral flow immunoassay (LFIA) for rapid detection and quantification of total anti-SARS-CoV-2 S-RBD …

FM Shurrab, N Younes, DW Al-Sadeq, N Liu… - International Journal of …, 2022 - Elsevier
Background A vast majority of the commercially available lateral flow immunoassay (LFIA) is
used to detect SARS-CoV-2 antibodies qualitatively. Recently, a novel fluorescence-based …

The spike of SARS-CoV-2: uniqueness and applications

R Kumavath, D Barh, BS Andrade, M Imchen… - Frontiers in …, 2021 - frontiersin.org
The Spike (S) protein of the SARS-CoV-2 virus is critical for its ability to attach and fuse into
the host cells, leading to infection, and transmission. In this review, we have initially …

[HTML][HTML] Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana

PK Quashie, JK Mutungi… - Wellcome Open …, 2021 - wellcomeopenresearch.org
Background: We set out to estimate the community-level exposure to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in Ghana. Methods: Phased …

Utilization of a glucometer test strip and enzymatic reactions to quantify anti-SARS-CoV-2 spike RBD IgG antibody and SARS-CoV-2 virus in saliva and serum

F Hossain, Q Shen, N Balasuriya, JLM Law… - Analytical …, 2023 - ACS Publications
A sensor capable of quantifying both anti-SARS-CoV-2 spike receptor-binding domain
(RBD) antibody levels and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

Hematological, inflammatory, and novel biomarkers assessment as an eminent strategy for clinical management of COVID-19

S Rezaeian, F Razmjooei, M Pourmokhtari, A Abdoli… - Heliyon, 2023 - cell.com
Background Different biomarkers have been suggested as novel biomarkers of coronavirus
disease 2019 (COVID-19) theragnosis. With the aim of having a better clinical management …